Improving lymphatic drainage with vascular endothelial growth factor C (VEGF-C) (Mesquita et al., 2018), for example, can enhance T cell-based immunotherapy against gliomas (Song et al., 2020). The gene discussed is VEGFC; the disease is glioma.